Drug Cost Management Report

View more issues:

Articles in Nov, 2002 issue of Drug Cost Management Report

• The evolving PBM marketplace: emerging threats and future opportunities
  by Tim Watson
• AdvancePCS announced it will buy Accordant Health Services, a small disease management company - Contracts and Alliances in Brief
• Payers are figuring out how to take advantage of lower Canadian drug prices - Drug Cost Strategies in Brief
• Confusion over Medicaid regulations led the TogetherRx discount drug program for seniors to scale back its discounts for a few days - Legal News in Brief
• Aetna takes mail-order in-house; ends contract with Express Scripts
• First Health Services Corporation has a new contract with the state of Nevada - FHSC - Contracts and Alliances in Brief
• Employers seek pharmacy data to support benefit decisions
• The fight continues to get generic versions of Prilosec on the market - Legal News in Brief
• Expanding cholesterol drug market leads to increased health plan costs; get ready for super-statins
• HMOs will increase renewal rates by approximately 17% in 2003, but this is higher than the 12.5% rate of increase in prescription drug spending in 2002 - Drug Cost Studies in Brief
• Two health plans implement specialty pharmacy services
• Prime Therapeutics is losing 33 pharmacies from its Minnesota network - Contracts and Alliances in Brief
• Blue Cross Blue Shield of Michigan is expanding its successful generic promotion program - Drug Cost Strategies in Brief
• Massachusetts Medicaid has set new pharmacy reimbursement rates that pharmacies can live with - State News in Brief
• Higher drug copayments equal lower drug costs for employers - Drug Cost Studies in Brief
• Coming in December
• Pharmaceutical Care Network , has unveiled a new Web site to process prior authorization requests more efficiently - PCN - PARs - Drug Cost Strategies in Brief
• Oklahoma Medicaid wants to limit recipients to five prescriptions per month - State News in Brief
• Kaiser Permanente proposed a prescription drug benefit capped as low as $500 per year, but the plan was rejected - Drug Cost Strategies in Brief
• Anthem Prescription Management is making some changes - Company News in Brief